Combination of Oral Rigosertib and Injectable Azacitidine in Patients with Myelodysplastic Syndromes (MDS). (April 2017) - Navada, S.; Garcia-Manero, G.; Hearn, K.; Odchimar-Reissig, R.; Demakos, E.; Fenaux, P.; Petrone, M.; Zbyszewski, P.; Fruchtman, S.; Silverman, L.